The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious response from the company. In a statement, the company says the FDA's ...

Cycle Pharma makes $466m takeover bid for Vanda UK group Cycle Pharma has made an unsolicited takeover bid to buy Vanda Pharma of the US, which is already fending off an overture from Future Pak.

Read about Vanda Pharmaceuticals Inc (VNDA:XNAS) stock and today's latest news and financial updates.